Wed, Oct 22, 2014, 8:45 AM EDT - U.S. Markets open in 45 mins.

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • techtrader79 techtrader79 Jun 5, 2012 12:02 AM Flag

    How could hailstorm be so wrong?

    Hail, how? How could you be so wrong? What will it take $20/share? $30/share? The move on Synta hasn't even begun. Ganetespib is a 1 Billion dollar drug, totally un-partnered, which means Synta OWNS ALL THE REVENUE ON APPROVAL! Wait until that tidbit sinks in, Synta OWNS IT ALL!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This post of yours got five stars.

      THAT is a perfect example of why I stayed away, and why future visits are likely to be more infrequent. Nothing but a bunch of insane kool-aid drinking cheerleaders around here. It's a waste of time coming here and being the voice of reason for people who's hormones are flowing like a teenager getting to second base for the first time.

      Synta owns it all? Good...maybe they can sell it to farmers as fertilizer, and make some of their sunk costs back.

      Now that the hopium is starting to wear off, if y'all want to read the wisdom I have to impart, go back through the archives, because I've nothing new to say. I'm just sticking around to gloat.

    • I do like the SNTA price rise, but it is too soon to gloat as we haven't seen the NSCLC data for the phase 2b part of the Galaxy trial. SNTA management says we will see the data in July and they are very confident but we still need to see the data. Consider the time before then as akin to the pre-ASCO rise that is often seen.

    • Things are looking up for sure.

      Where did you get your $1 billion estimate? The only estimate I've seen was from BMO and they said maximum revenue was at $650 million.

 
SNTA
3.06-0.07(-2.24%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.